Emergence of cross-resistance to beta-lactam antibiotics in fecal Escherichia coli and Klebsiella strains from neonates treated with ampicillin or cefuroxime.
Both ampicillin and cefuroxime therapy of neonates selected drug- and species-dependent beta-lactam resistance patterns in fecal strains of Escherichia coli and Klebsiella spp. This was in contrast to our previous findings that ampicillin, but not cefuroxime, contributed to the emergence of beta-lactam resistance also by the promotion of nosocomial spread of resistant strains.
Tullus
K
K
Department of Pediatrics, Danderyd Hospital, Sweden.
Berglund
B
B
Burman
L G
LG
D000667:Ampicillin / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002444:Cefuroxime / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects*; D005243:Feces / Q000382:microbiology*; D006801:Humans; D007231:Infant, Newborn; D007709:Klebsiella / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D010641:Phenotype; D013548:Sweden
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D000667:Ampicillin; D002444:Cefuroxime